A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)

Research Site 7, Park Ridge, Illinois, United States

Research Site 2, New York, New York, United States

Research Site 1, Cincinnati, Ohio, United States

Research Site 14, Pittsburgh, Pennsylvania, United States

Research Site 13, Camperdown, New South Wales, Australia

Research Site 9, Saint Leonards, New South Wales, Australia

Research Site 21, Heidelberg, Victoria, Australia

Research Site 3, Nedlands, Western Australia, Australia

Research Site 40, Innsbruck, Austria

Research Site 39, Linz, Austria

Research Site 42, Vienna, Austria

Research Site 37, Vienna, Austria

Research Site 33, La Louvière, Belgium

Research Site 34, Leuven, Belgium

Research Site 24, Cerqueira César, São Paulo, Brazil

Research Site 5, Vancouver, British Columbia, Canada

Research Site 6, Chicoutimi, Quebec, Canada

Research Site 4, Québec, Canada

Research Site 30, Hradec Králové, Czechia

Research Site 23, Paris, France

Research Site 17, Tbilisi, Georgia

Research Site 18, Tbilisi, Georgia

Research Site 19, Tbilisi, Georgia

Research Site 35, Berlin, Germany

Research Site 10, Jerusalem, Israel

Research Site 15, Tel Litwinsky, Israel

Research Site 26, Kanazawa, Ishikawa-ken, Japan

Research Site 27, Suita, Osaka, Japan

Research Site 20, Fukushima, Japan

Research Site 16, Okayama, Japan

Research Site 22, Saitama, Japan

Research Site 25, Tokyo, Japan

Research Site 12, Christchurch, New Zealand

Research Site 31, Riyadh, Saudi Arabia

Research Site 11, Parktown, Johannesburg, South Africa

Research Site 8, Cape Town, South Africa

Research Site 28, Córdoba, Spain

Research Site 29, Madrid, Spain

Research Site 32, Gothenburg, Sweden

Research Site 36, Afyonkarahisar, Turkey (Türkiye)

Research Site 41, Bornova/Izmir, Turkey (Türkiye)

Research Site 38, Melikgazi/Kayseri, Turkey (Türkiye)